Last €6.30 EUR
Change Today -0.05 / -0.79%
Volume 9.8K
As of 4:36 AM 03/6/15 All times are local (Market data is delayed by at least 15 minutes).

stentys (STNT) Snapshot

Open
€6.36
Previous Close
€6.35
Day High
€6.36
Day Low
€6.29
52 Week High
03/11/14 - €11.33
52 Week Low
10/16/14 - €3.79
Market Cap
73.8M
Average Volume 10 Days
193.8K
EPS TTM
€-1.06
Shares Outstanding
11.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for STENTYS (STNT)

Related News

No related news articles were found.

stentys (STNT) Related Businessweek News

No Related Businessweek News Found

stentys (STNT) Details

STENTYS Société anonyme, a medical technology company, engages in the development and commercialization of self-apposing stents to treat acute myocardial infarction, bifurcation lesions, and other complex coronary diseases in European countries. The company’s Self-Apposing stent technology consists of a self-expanding stent platform to treat coronary arteries with ambiguous vessel diameters or with areas of vessel diameter fluctuations. Its products portfolio includes the Self-Apposing STENTYS bare metal stents and DES (P) stents; and the STENTYS AC aspiration catheter, a deliverable thrombectomy device for thrombus-containing lesions. The company serves interventional cardiologists in Europe, the Middle East, and Asia. STENTYS Société anonyme was founded in 2006 and is headquartered in Paris, France.

38 Employees
Last Reported Date: 04/30/14
Founded in 2006

stentys (STNT) Top Compensated Officers

Co-Founder, Chief Executive Officer and Direc...
Total Annual Compensation: €213.8K
Co-Founder and Member of Scientific Advisory ...
Total Annual Compensation: --
Compensation as of Fiscal Year 2013.

stentys (STNT) Key Developments

STENTYS Announces Consolidated Revenue Results for the Fourth Quarter and Full Year Ended December 31, 2014

STENTYS announced consolidated revenue results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported revenues of EUR 1,038,700 compared to EUR 986,900 a year ago. For the year, the company reported revenues of EUR 3,851,000 compared to EUR 3,393,600 year ago. For the year, revenues were up 13% at EUR 3.9 million. The enhancement of the product portfolio, following the CE marking of the new Sirolimus-eluting stent (STENTYS SES), commenced at the very end of the year and contributed little to annual sales.

STENTYS Enters into Five Year Agreement with Micell Technologies Inc

STENTYS announced it has entered into a five year agreement with Micell Technologies Inc. to be the exclusive distributor of the MiStent coronary stent worldwide (excluding the United States, Canada, China, South Korea and Japan).

STENTYS Reports Revenues Results for the Third Quarter and Nine Months Ended September 30, 2014

STENTYS reported revenues results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported Revenue was €876.5 million compared to €768.0 million a year ago. This growth was driven by sales of its current range of self-apposing stents both directly via the Company and through its network of distribution partners in various regions around the world. For the nine months, the company reported Revenue was €2,812.4 million compared to €2,406.6 million a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
STNT:FP €6.30 EUR -0.05

STNT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $47.44 USD +0.43
Boston Scientific Corp $16.97 USD +0.18
InspireMD Inc $0.28 USD -0.009
Medtronic PLC $78.50 USD +0.31
Sorin SpA €3.01 EUR -0.004
View Industry Companies
 

Industry Analysis

STNT

Industry Average

Valuation STNT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 15.4x
Price/Book 2.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 9.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact STENTYS, please visit www.stentys.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.